HER2-negative Breast Cancer Patients With Brain Metastases trials recruiting in New York

Fewer than 3 recruiting trials found.

All HER2-negative Breast Cancer Patients With Brain Metastases trials nationally

Cities in New York

Recruiting trials in New York

• A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
  NCT06764940 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Stony Brook